Within recent years the effect of the First Amendment on FDA-controlled speech has drastically changed. Courts have stated standards for what FDA can do in controlling speech in advertisements. The difficult question is predicting the practical impact of these court decisions. FDA still has enormous authority to control speech and labeling. This presentation discusses the balance between FDA control of indications versus court restrictions on FDA control of speech.
Device Advertising and the First Amendment: Your Rights was presented by Robert J. Klepinski, of Fredrikson & Byron and aired 2007-08-23. This audio conference will be replayed on Wednesday, December 17, 2008 by popular demand. For more details or to register for this conference please visit our site www.fxconferences.com
